← FDA DRUG APPROVALS

FDA NDA · NDA010599

TRAL

Sponsor: ABBVIE

APPLICATION
NDA010599
TYPE
NDA
ORIGINAL APPROVAL
1957-02-13
LATEST ACTION
1988-04-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRALDiscontinued
HEXOCYCLIUM METHYLSULFATE 25MG · TABLET · ORAL

Approval history

1988-04-14Labeling · Supplement 14AP
1980-10-07Labeling · Supplement 12AP
1980-10-07Labeling · Supplement 10AP
1980-10-07Labeling · Supplement 11AP
1957-02-13Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →